Corr Joins Celtic

Peter B. Corr is joining Stephen Evans-Freke as a general partner in Celtic Therapeutics Management, a global private equity firm formed to build on the investment model established by Celtic Pharma. Celtic Therapeutics is expected to operate on a significantly larger scale than Celtic Pharma. Corr is a retired Pfizer Inc. executive. He served as senior vice president, science and technology from 2002 to 2006. www.celticpharma.com